Fundamentalsinfo compiles publicly available fundamental information on Indian listed companies to help you do your own analysis.

All Reports

Blue Jet Healthcare Limited

NSE: BLUEJETSmall Cap

Current Price

437.45

As of 20 May 2026

Market Cap

₹7.30K Cr

As of 20 May 2026

Two Companies Stacked: Mature Contrast-Media Franchise + CDMO Bet (Mahad + Vizag + Hyderabad R&D)

Report updated: 2026-05-16

fundamentalsinfo.comLive

Blue Jet Healthcare Limited

NSE: BLUEJET· Small Cap

Boutique specialty CDMO supplying 3 of 4 global contrast-media innovators — three segments: contrast-media intermediates (GE Healthcare, Bracco, Guerbet), pharma intermediates/API (bempedoic acid patent-protected to 2031), and high-intensity sweeteners. Now spending Rs.1,340 Cr across Mahad, Vizag and Hyderabad to build a second growth engine by FY28.

Rs.438

Share price (May 2026)

Down ~64% from Apr-25 peak Rs.905

Rs.13,500 Cr

Market cap (Mid Cap)

Rs.1,030 Cr

FY25 revenue (+45% YoY)

9M FY26 Rs.713 Cr — flat YoY

Rs.305 Cr

FY25 PAT (+86% YoY)

TTM P/E ~26x

31%

9M FY26 EBITDA margin

Below mid-30s guide; Q3 dipped to 24%

79.81%

Promoter holding (Mar 2026)

Must drop to <=75% by Oct/Nov 2026

Stock Funda Summary

  • Boutique pharma/specialty CDMO (BSE 544009 / NSE BLUEJET).
  • Three segments: Contrast Media Intermediates (supplies 3 of 4 global innovators — GE Healthcare, Bracco, Guerbet), Pharma Intermediates/API (dominated by bempedoic acid intermediate, patent to 2031), and High-Intensity Sweeteners (~10% global saccharin share).
  • FY25 revenue Rs.1,030 Cr (+45%), PAT Rs.305 Cr (+86%) — but 9M FY26 reverted to flat, with the stock down ~64% from Apr-25 peak Rs.905 to Feb-26 low Rs.327 (recovered to ~Rs.438 May-26).
  • The bull case rests on Rs.1,340 Cr cumulative capex (Mahad Rs.300 Cr backward-integration, Vizag Rs.1,000 Cr greenfield 4-block CDMO, Hyderabad Rs.40 Cr R&D for peptides/GLP-1) converting into a real second growth engine FY27-28 — before the mature contrast-media core defines the story.
  • Promoter Arora family 79.81%, must drop to 75% by Oct/Nov 2026 (MPS overhang).
  • One operational red flag: Nov-2023 Mahad plant fire (11 worker deaths) at the same site now hosting the Rs.300 Cr capex.
  • Live event timeline tracks every BSE filing, concall, capex update, and innovator-qualification announcement.

Educational content only. Not SEBI-registered investment advice. This is public source-based data. Do your own analysis.